Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |